To validate the analysis results of TCGA database, we analyzed the copy numbers of 100 GBM patients’ samples from our tumor banks by Taqman Copy Number Assay using fluorescent probes targeting LANCL2 and EGFR. The log2 copy number value larger than 2 was regarded as amplification. Here, LANCL2 is linked to glioblastoma.